FFilingSight

Not investment advice. FilingSight is an automated analytical research tool, not a registered investment advisor. Ratings and scores are quantitative analytical classifications, not buy or sell recommendations. Nothing here is personalized to your circumstances. Investing involves risk of loss — consult a licensed professional. See full disclosures.

Create a free account to read 3 full reports each month — plus a 14-day Pro trial. Get started →

CME Group Inc.

CMEFinancials

Generated Jul 5, 2026, 08:13 PM UTC

analytical score 6

CME (CME Group Inc.) analytical snapshot. Revenue grew +11.1% YoY to $5.58B. 5-year revenue CAGR +2.8%; 10y CAGR +6.7%. Net margin at 37.75% (contracting ▼). Market cap $15.77B at $236.60 per share. Trailing P/E 26.70, P/S 2.83, P/B 0.59. EV/Operating income ≈ 3.89 (EV $13.38B). Risk: Elevated. Macro: Risk-on · Supportive. Composite analytical score 6 (data confidence 81%). Descriptive analytics from public filings — not investment advice.

Market cap
$15.77B
66.64M shares
Price
$236.60
NMS
P/E (ttm)
26.70
Revenue (FY)
$5.58B
YoY +11.1%
Net margin
37.75%
▼ 5.36pp
Free cash flow
$3.38B
60.54% margin
Risk level
Elevated

Free SEC analysis

— computed from SEC filings, free to read
Free previewFundamentals Analyst

Fundamentals

Fundamentals Analyst
score 15Stable
80% conf

Revenue grew +11.1% YoY to $5.58B. 5-year revenue CAGR +2.8%; 10y CAGR +6.7%. Net margin at 37.75% (contracting ▼).

  • Revenue grew +11.1% YoY to $5.58B.
  • 5-year revenue CAGR +2.8%; 10y CAGR +6.7%.
  • Net margin at 37.75% (contracting ▼).
  • Return on equity 7.95%, ROA 1.53%, ROIC 12.97%.
  • Gross margin 0.00%, operating margin 61.58%.
  • Free cash flow margin 60.54% ($3.38B).
  • Net income down ▼ +34.7% YoY.
  • Asset turnover 0.03 — capital efficiency.
Revenue (FY)
$5.58B
YoY +11.1%
Net margin
37.75%
▼ 5.36pp
ROE
7.95%
ROA 1.53%
ROIC
12.97%
EPS (diluted)
$8.86
FY2025
Free cash flow
$3.38B
60.54% margin
Debt / equity
Cash $2.39B
Current ratio
1.02
Equity $26.62B
Annual fundamentals — up to 10 years (SEC 10-K, US-GAAP)
FYRevenueRev YoYGross%Op%Net%FCFROE%
2016$3.11B0.0056.8236.21$1.15B5.48
2017$3.33B+6.9%0.0059.7811.06$1.42B1.76
2018$3.60B+8.1%0.0061.2142.67$1.64B7.46
2019$3.64B+1.4%0.0063.40111.49$1.67B19.98
2020$4.31B+18.2%0.0060.5145.53$2.32B7.51
2021$4.87B+13.0%0.0053.1643.48$2.43B8.04
2022$4.88B+0.3%0.0054.0143.11$2.52B7.68
2023$4.69B-4.0%0.0056.4056.22$2.28B9.81
2024$5.02B+7.0%0.0060.0864.27$2.97B12.07
2025$5.58B+11.1%0.0061.5837.75$3.38B7.95
Quarterly revenue trend (last 6 quarters, SEC 10-Q)
Quarter endRevenueYoYQoQNet margin
Mar 31, 2025$1.64B+10.4%
Jun 30, 2025$3.33B+10.4%+103.0%
Jun 30, 2025$1.69B-44.0%-49.3%
Sep 30, 2025$4.87B+5.8%+187.9%
Sep 30, 2025$1.54B-66.6%-68.4%
Mar 31, 2026$1.88B+14.5%+22.3%
Revenue (annual, SEC 10-K)
2016: 3,113
2017: 3,327
2018: 3,595
2019: 3,645
2020: 4,309
2021: 4,868
2022: 4,884
2023: 4,690
2024: 5,019
2025: 5,579
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Profitability trends (%)
0.027.955.883.6111.5201620182020202220242025
GrossOperatingNet
Free cash flow (annual)
2016: 1,151
2017: 1,418
2018: 1,640
2019: 1,669
2020: 2,324
2021: 2,427
2022: 2,518
2023: 2,275
2024: 2,966
2025: 3,377
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free previewRegulatory Analyst

Filings & Ownership

Regulatory Analyst
score 30Improving
80% conf

Latest annual report (10-K) filed Feb 26, 2026. Latest quarterly report (10-Q) filed Apr 24, 2026. 11 recent 8-K material-event filings in the index.

  • Latest annual report (10-K) filed Feb 26, 2026.
  • Latest quarterly report (10-Q) filed Apr 24, 2026.
  • 11 recent 8-K material-event filings in the index.
  • Recent insider Form 4s: 0 buy vs 0 sell transactions.
  • ~10,000+ recent 13F-HR filings reference CME Group Inc.; broad institutional reporting.
  • Recent filers include MARK MORRIS ET AL, WINNOW WEALTH LLC, Walleye Trading LLC.
  • 1 recent 13D activist/beneficial-ownership filings — potential catalyst.
  • 19 recent 13G passive institutional ownership notices.
Latest 10-K
Feb 26, 2026
Annual report
Latest 10-Q
Apr 24, 2026
8-K (recent)
11
Insider net
0B/0S
13F filers
10k+
Activist 13D
1
Recent 13F institutional filers (SEC EDGAR full-text)
FilerFormFiled
MARK MORRIS ET AL13F-HRFeb 13, 2008
WINNOW WEALTH LLC13F-HRAug 21, 2025
Walleye Trading LLC13F-HRNov 6, 2007
CTC Fund Management LLC13F-HRMay 15, 2012
Capital Wealth Planning, LLC13F-HRAug 13, 2018
Recent 8-K material events
DateFormDescription
Jun 17, 20268-K8-K
Jun 10, 20268-K8-K
May 19, 20268-K8-K
Apr 27, 20268-K8-K
Apr 22, 20268-K8-K
Feb 4, 20268-K8-K
Feb 2, 20268-K8-K
Oct 22, 20258-K8-K
Free previewSEC Filing Analyst

SEC Filing Deep-Analysis

SEC Filing Analyst
score 0Stable
60% conf

No significant implicit signals detected. Key metrics are changing within normal ranges.

  • Endogenous analysis: No significant implicit signals detected in the latest filing. Key metrics are changing within normal ranges — the filing appears consistent with prior-period patterns.
  • 8 new XBRL disclosure(s) in latest filing — expanding reporting scope.
  • 20 disclosure(s) dropped from prior year — reduced reporting granularity.
Revenue
$5.58B
+11.1% YoY
Operating income
$3.44B
+13.9% YoY
Net income
$3.23B
+22.4% YoY
Operating cash flow
$3.45B
+13.0% YoY
Capex
$76.4M
-14.8% YoY
Total assets
$137.45B
+6.0% YoY
Total liabilities
$110.96B
+7.8% YoY
Cash & equivalents
$2.91B
+7.1% YoY
Filing quality score
75/100
8 new disclosures
SEC XBRL metric changes (latest annual vs prior)
MetricPrior yearLatest yearChange% Change
Revenue$5.02B$5.58B$559.5M+11.1%
Operating income$3.02B$3.44B$419.8M+13.9%
Net income$2.64B$3.23B$589.8M+22.4%
Operating cash flow$3.06B$3.45B$397.8M+13.0%
Capex$89.7M$76.4M$-13.3M-14.8%
Total assets$129.71B$137.45B$7.74B+6.0%
Total liabilities$102.97B$110.96B$7.99B+7.8%
Cash & equivalents$2.72B$2.91B$191.9M+7.1%
Stockholders equity$26.74B$26.49B$-251.0M-0.9%
Accounts receivable$535.6M$573.1M$37.5M+7.0%
XBRL disclosure changes (new vs dropped concepts)
TypeConcepts
AddedConversionOfStockSharesConverted1, ConvertiblePreferredStockSharesIssuedUponConversion, EquitySecuritiesWithoutReadilyDeterminableFairValueAmount, EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount, IncrementalCommonSharesAttributableToConversionOfPreferredStock, NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted, OtherInvestmentNotReadilyMarketableFairValue, UndistributedEarningsLossAvailableToCommonShareholdersBasic
RemovedAllocatedShareBasedCompensationExpense, AllowanceForDoubtfulAccountsReceivable, CommonStockDividendsPerShareDeclared, ComprehensiveIncomeNetOfTax, CurrentFederalTaxExpenseBenefit, CurrentForeignTaxExpenseBenefit, CurrentIncomeTaxExpenseBenefit, CurrentStateAndLocalTaxExpenseBenefit, DeferredFederalIncomeTaxExpenseBenefit, DeferredForeignIncomeTaxExpenseBenefit
Risk language in filing text (EDGAR full-text search)
TermSeverityRecentPriorStatus
Restructuringmedium573Ongoing
Filing signal breakdown
Red flags: 0
Positive: 0
Watch: 0
Red flags
Positive
Watch

Unlock the rest

  • Valuation
    Market cap $15.77B at $236.60 per share.
    Pro
  • Price & Technicals
    Price $236.60 — downtrend (below 200-DMA); 1-month momentum negative.
    Pro
  • Macro & Rates
    Market regime: Risk-on · Supportive.
    Pro
  • Risk Scorecard
    Composite risk: Elevated.
    Pro

This content is for Pro subscribers

Unlock the full breakdown from all analysts — valuation (DCF & Graham), price & technicals, macro, risk scorecard, and 13F/13D ownership flow — plus your research workspace.

3 sections free · 4 Pro sections locked · composite 6

Macro exposure

Rate-sensitive · High sensitivity
Neutral

Macro regime: Risk-on · Supportive. CME Group Inc. is a rate-sensitive name (high macro sensitivity) — a supportive backdrop, though defensives lag risk-on tapes.

Macro regime
Risk-on · Supportive
Yield curve
Normal
VIX
16.59
Fed funds
3.63%
CPI YoY
+4.2%

Analytical read

deterministic preview

Market cap $15.77B at $236.60 per share..

Risk
Elevated
Macro regime
Risk-on · Supportive
Macro exposure
Neutral
Descriptive analytics from public filings and macro data — not investment advice.

Peer comparison

Rate-sensitive group

How CME stacks up against tracked peers with similar macro sensitivity — by analytical score and macro exposure.

CompanyScoreMacro
Capital One Financial COF23Neutral
Chubb Ltd. CB23Neutral
U.S. Bancorp USB17Neutral
JPMorgan Chase & Co. JPM16Neutral
Prologis Inc. PLD14Neutral
Simon Property Group SPG13Neutral
American Express Co. AXP11Neutral
Bank of America Corp. BAC11Neutral
Visa Inc. V8Neutral
Mastercard Inc. MA8Neutral
Public Storage PSA8Neutral
Dominion Energy D6Neutral
Charles Schwab Corp. SCHW6Neutral
CME Group Inc. CME● you6Neutral
PNC Financial Services PNC4Neutral
Realty Income Corp. O4Neutral
Travelers Cos. TRV2Neutral
Duke Energy Corp. DUK0Neutral
Bank of New York Mellon BK0Neutral
Marsh & McLennan MMC0Neutral
Equity Residential EQR0Neutral
Wells Fargo & Co. WFC-1Neutral
Welltower Inc. WELL-1Neutral
Exelon Corp. EXC-3Neutral
NextEra Energy NEE-4Neutral
Xcel Energy XEL-5Neutral
American International Group AIG-5Neutral
Truist Financial TFC-5Neutral
Digital Realty Trust DLR-6Neutral
Allstate Corp. ALL-7Neutral
S&P Global SPGI-8Neutral
American Water Works AWK-9Neutral
Goldman Sachs Group GS-10Neutral
Citigroup Inc. C-11Neutral
Moody's Corp. MCO-13Neutral
Morgan Stanley MS-13Neutral
MetLife Inc. MET-13Neutral
Southern Company SO-15Neutral
BlackRock Inc. BLK-15Neutral
Equinix Inc. EQIX-16Neutral
American Electric Power AEP-18Neutral
Crown Castle Inc. CCI-18Neutral
American Tower Corp. AMT-39Neutral